Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis. (2022)

First Author: Godolphin PJ

Attributed to: Method Meta-analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0270668

PubMed Identifier: 35802687

Publication URI: http://europepmc.org/abstract/MED/35802687

Type: Journal Article/Review

Volume: 17

Parent Publication: PloS one

Issue: 7

ISSN: 1932-6203